Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.4420
+0.0180 (4.25%)
At close: Oct 9, 2026, 4:00 PM EDT
0.4560
+0.0140 (3.17%)
After-hours: Oct 9, 2026, 7:49 PM EDT
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $8.61 million as of October 9, 2026. It is the 42,490th most valuable company in the world and the 5,745th biggest in the United States. Its market cap has decreased by 44.10% in one year.
Market Cap
8.61M
Enterprise Value
1.64M
1-Year Change
-44.10%
Global Rank
Country Rank
#5,745 United States
Category
ChartMarket Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $8.61M, a decrease of -87.82%. That is a compound annual growth rate of -18.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 8.60M | 28.36% |
| Dec 31, 2025 | 6.70M | 31.37% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
| Jun 2, 2016 | 70.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 9.93M |
| MetaVia | 9.62M |
| Ensysce Biosciences | 8.35M |
| Azitra | 8.00M |
| CNS Pharmaceuticals | 7.94M |
| FibroBiologics | 7.93M |
| Longeveron | 7.78M |
| Soligenix | 7.69M |